Akari Therapeutics Stock Forecast

Buy or Hold candidate since May 21, 2026 Gain 184.63%

The Akari Therapeutics Plc stock price fell by -2.47% on the last day (Wednesday, 10th Jun 2026) from $15.00 to $14.63. During the last trading day the stock fluctuated 12.68% from a day low at $14.11 to a day high of $15.90. The price has been going up and down for this period, and there has been a -8.13% loss for the last 2 weeks. Volume has increased on the last day by 23 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 39 thousand shares were bought and sold for approximately $569.77 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 54.61% during the next 3 months and, with a 90% probability hold a price between $8.12 and $35.90 at the end of this 3-month period.

AKTX Signals & Forecast

The Akari Therapeutics Plc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $15.09. On a fall, the stock will find some support from the long-term average at approximately $9.12. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -33.65%. Further fall is indicated until a new bottom pivot has been found. Akari Therapeutics Plc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Akari Therapeutics Plc stock

On the downside, the stock finds support just below today's level from accumulated volume at $13.43. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.79 between high and low, or 12.68%. For the last week, the stock has had daily average volatility of 10.74%.

Our recommended stop-loss: $13.94 (-4.70%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (AKTX) For The Upcoming Trading Day Of Thursday 11th

For the upcoming trading day on Thursday, 11th we expect Akari Therapeutics Plc to open at $14.88, and during the day (based on 14 day Average True Range), to move between $13.22 and $16.04, which gives a possible trading interval of +/-$2.83 (+/-21.40%) up or down from last closing price. If Akari Therapeutics Plc takes out the full calculated possible swing range there will be an estimated 21.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $13.43 (8.20%) than the resistance at $16.43 (12.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Akari Therapeutics Plc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Akari Therapeutics Plc stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.500 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 11, 2026 - $14.88 ( 1.71%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk